Opiant Pharmaceuticals Announces FDA Acceptance and Priority Review of NDA for OPNT003, Nasal Nalmefene, for Opioid Overdose
FDA sets PDUFA date of May 22, 2023 SANTA MONICA, Calif., Jan. 19, 2023 (GLOBE…
FDA sets PDUFA date of May 22, 2023 SANTA MONICA, Calif., Jan. 19, 2023 (GLOBE…
AMB-05X is the First and Only Investigational Drug Candidate to Receive PRIME Designation for the…
LOS ANGELES–(BUSINESS WIRE)–RBB Bancorp (NASDAQ: RBB) and its subsidiaries, Royal Business Bank (“the Bank”) and…
DENVER–(BUSINESS WIRE)–Sunflower Bank, N.A. is thrilled to announce the launch of a new small business…
Former Nordstrom executive will lead the company’s digital transformation to reach previously announced growth targets….
New York, New York–(Newsfile Corp. – January 19, 2023) – Black Mountain Investment Group is…
London, United Kingdom–(Newsfile Corp. – January 19, 2023) – TRESORFX, a leading provider of online…
Times 10 Publications has released Dear Math, a book intended for educators who wish to…
SAN FRANCISCO & WASHINGTON–(BUSINESS WIRE)–Orrick, Herrington & Sutcliffe LLP / Buckley: Orrick and Buckley jointly…
MacMillan Will Guide Future Strategy for Company’s U.S. Services Business TYSONS, Va.–(BUSINESS WIRE)–Maximus, a leading…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to four classes of notes issued by Mulligan Asset…
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Informatica, the first enterprise cloud data management leader to earn certification under…
DALLAS–(BUSINESS WIRE)–Predicta (www.predicta.com/blog) used AI to evaluate differences in professional EV reviews and the lived…
SAN FRANCISCO–(BUSINESS WIRE)–Alpine Investors, a people-driven private equity firm that invests in software and services…
BERWYN, Pa.–(BUSINESS WIRE)–Coho Partners, Ltd. is pleased to announce an addition to its Investment Team,…
Master Tour launches the industry’s first and only comprehensive production workflow, connecting tour and venue…
TEL AVIV, Israel, Jan. 19, 2023 (GLOBE NEWSWIRE) — Legit Security, a cyber security company…
VALNEVA Declaration of shares and voting rightsStatus on December 31, 2022 (corrected data) and January…
— First ‘living medicine’ to treat antibiotic-resistant Pseudomonas aeruginosa infections in the lung, a leading…
Company Announcement COPENHAGEN, Denmark; January 19, 2023 – Genmab A/S (Nasdaq: GMAB) Correction: In company…